Edunn Biotechnology's Other Investors

Edunn Biotechnology raised a round of funding on , . Investors include St. Louis Arch Angels.

Edunn Biotechnology, Inc. is developing oligonucleotide drugs to treat central nervous system diseases. The company currently has two drugs in development. Edunn's OL-1 drug is designed to cure Alzhei…

Articles about Edunn Biotechnology's Other Investors: